CEL-SCI (FRA:LSR) Other Stockholders Equity: €-0.00 Mil (As of Mar. 2026)


FRA:LSR CEL-SCI Corp FRA:LSR
25 GF Score
Price €1.06
! 2 Warning Signs
View Full Analysis

What is CEL-SCI Other Stockholders Equity?

CEL-SCI FRA:LSR +39.47% 25 Other Stockholders Equity is €-0.00 Mil as of Mar. 2026. GuruFocus rates FRA:LSR with a GF Score™ of 25/100. The stock has 2 warning signs investors should review.

CEL-SCI's Other Stockholders Equity for the quarter that ended in Mar. 2026 was €-0.00 Mil.

CEL-SCI's quarterly Other Stockholders Equity increased from Sep. 2025 (€-0.00 Mil) to Dec. 2025 (€0.00 Mil) but then declined from Dec. 2025 (€0.00 Mil) to Mar. 2026 (€-0.00 Mil).

CEL-SCI's annual Other Stockholders Equity increased from Sep. 2023 (€-0.00 Mil) to Sep. 2024 (€-0.00 Mil) but then declined from Sep. 2024 (€-0.00 Mil) to Sep. 2025 (€-0.00 Mil).

CEL-SCI Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for CEL-SCI's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CEL-SCI Other Stockholders Equity Chart

CEL-SCI Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.00 0.00 -0.00 -0.00 -0.00

CEL-SCI Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.00 -0.00 0.00 -0.00
FRA:LSR
25GF Score
CEL-SCI Corp FRA:LSR
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CEL-SCI Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of €-0.00 Mil mean?
CEL-SCI (FRA:LSR) has a Other Stockholders Equity of €-0.00 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on CEL-SCI and its competitors.
Is CEL-SCI's Other Stockholders Equity too high?
CEL-SCI's current Other Stockholders Equity is €-0.00 Mil. Overall, CEL-SCI has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does CEL-SCI's Other Stockholders Equity compare to OTLC and AEON?
CEL-SCI's Other Stockholders Equity of €-0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on CEL-SCI and its competitors. CEL-SCI's current Other Stockholders Equity is €-0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CEL-SCI stock overvalued right now?
CEL-SCI (FRA:LSR) has a current Other Stockholders Equity of €-0.00 Mil. The current Other Stockholders Equity is €-0.00 Mil. CEL-SCI's overall GF Score™ is 25/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For CEL-SCI (FRA:LSR), the current Other Stockholders Equity is €-0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CEL-SCI Business Description

Other Exchanges CVM:USA
Address 8229 Boone Boulevard, Suite 802, Vienna, VA, USA, 22182
CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.
25GF Score

Get the complete analysis for FRA:LSR

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.06
Price